Exact Mass: 572.3560292
Exact Mass Matches: 572.3560292
Found 354 metabolites which its exact mass value is equals to given mass value 572.3560292
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dolichyl D-xylosyl phosphate
Ganoderic acid W
Ganoderic acid W is found in mushrooms. Ganoderic acid W is a constituent of Ganoderma lucidum (reishi).
Ganoderic acid Ma
Ganoderic acid Ma is found in mushrooms. Ganoderic acid Ma is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Ganoderic acid Ma is found in mushrooms.
Vitamin D2 3-glucuronide
Vitamin D2 3-glucuronide is a natural human metabolite of Vitamin D2 generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Vitamin D2 3-glucuronide is a natural human metabolite of Vitamin D2 generated in the liver by UDP glucuonyltransferase. D018977 - Micronutrients > D014815 - Vitamins > D004872 - Ergocalciferols
3'-N-Acetyl-4'-O-(14-methylpentadecanoyl)fusarochromanone
C33H52N2O6 (572.3825171999999)
3-N-Acetyl-4-O-(14-methylpentadecanoyl)fusarochromanone is produced by Fusarium equiseti. Production by Fusarium equiseti
Bioadykinin Fragment 1-5
C27H40N8O6 (572.3070660000001)
Chemistry 2
Dmap-ethyl-paf
C30H57N2O6P (572.3954031999999)
Ile-Ile-Ala-Glu-Lys
Tazemetostat
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid
12(R)-(6-O-acetyl-3-O-malonyl-beta-D-glucopyranosyloxy)octadecanoic acid 1,2-cyclic ester|gallicaside J
3beta-[(2-hydroxybenzoyl)oxy]glutina-5(10),6-dien-27,8alpha-olide|phyllenolide C
3beta,6beta-diacetoxy-19alpha-hydroxyurs-12-en-18-oic acid
3beta,12alpha-diacetoxy-7,8-dihydroholothurinogenin
(20S,22R)-5alpha-spirost-23(27)-en-2alpha,3beta,6beta-triol triacetate
2alpha,24?diacetoxy?3beta?hydroxyolean?12?en?28?oic acid
(20S,22S,25S)-furost-5-ene-22,25epoxy-2alpha,3beta,26-triol triacetate
(3b,11a,19b)-3-(butanoyloxy)-11-hydroxytaraxast-20(30)-ene-23,28-dioic acid|clerodendrumic acid
3-O-(alpha-L-arabinopyranosyl)-30-norolea-12,20(29)-dien-28-oic acid|3-O--30-norolea-12,20(29)-dien-28-oic acid|3-O--30-norolean-12,20(29)-dien-28-oic acid
13(R)-(6-O-acetyl-3-O-malonyl-beta-D-glucopyranosyloxy)octadecanoic acid 1,2-cyclic ester|gallicaside I
(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid
1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone
(3S,6R,12S)-6-benzyl-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
C31H48N4O6 (572.3573667999999)
1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone [IIN-based: Match]
1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone [IIN-based on: CCMSLIB00000845569]
(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid [IIN-based: Match]
(3S,6R,12S)-6-benzyl-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone [IIN-based on: CCMSLIB00000847982]
C31H48N4O6 (572.3573667999999)
(3S,6R,12S)-6-benzyl-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone [IIN-based: Match]
C31H48N4O6 (572.3573667999999)
(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid [IIN-based on: CCMSLIB00000845395]
(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid [IIN-based on: CCMSLIB00000845398]
(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid_major
Glu Ile Arg Arg
Glu Leu Arg Arg
Glu Arg Ile Arg
Glu Arg Leu Arg
Glu Arg Arg Ile
Glu Arg Arg Leu
Ile Glu Arg Arg
Ile Arg Glu Arg
Ile Arg Arg Glu
Ile Arg Val Trp
C28H44N8O5 (572.3434493999999)
Ile Arg Trp Val
C28H44N8O5 (572.3434493999999)
Ile Val Arg Trp
C28H44N8O5 (572.3434493999999)
Ile Val Trp Arg
C28H44N8O5 (572.3434493999999)
Ile Trp Arg Val
C28H44N8O5 (572.3434493999999)
Ile Trp Val Arg
C28H44N8O5 (572.3434493999999)
Lys Asn Arg Arg
C22H44N12O6 (572.3506603999999)
Lys Arg Asn Arg
C22H44N12O6 (572.3506603999999)
Lys Arg Arg Asn
C22H44N12O6 (572.3506603999999)
Leu Glu Arg Arg
Leu Arg Glu Arg
Leu Arg Arg Glu
Leu Arg Val Trp
C28H44N8O5 (572.3434493999999)
Leu Arg Trp Val
C28H44N8O5 (572.3434493999999)
Leu Val Arg Trp
C28H44N8O5 (572.3434493999999)
Leu Val Trp Arg
C28H44N8O5 (572.3434493999999)
Leu Trp Arg Val
C28H44N8O5 (572.3434493999999)
Leu Trp Val Arg
C28H44N8O5 (572.3434493999999)
Asn Lys Arg Arg
C22H44N12O6 (572.3506603999999)
Asn Gln Arg Arg
Asn Arg Lys Arg
C22H44N12O6 (572.3506603999999)
Asn Arg Gln Arg
Asn Arg Arg Lys
C22H44N12O6 (572.3506603999999)
Asn Arg Arg Gln
Gln Asn Arg Arg
Gln Arg Asn Arg
Gln Arg Arg Asn
Arg Glu Ile Arg
Arg Glu Leu Arg
Arg Glu Arg Ile
Arg Glu Arg Leu
Arg Ile Glu Arg
Arg Ile Arg Glu
Arg Ile Val Trp
C28H44N8O5 (572.3434493999999)
Arg Ile Trp Val
C28H44N8O5 (572.3434493999999)
Arg Lys Asn Arg
C22H44N12O6 (572.3506603999999)
Arg Lys Arg Asn
C22H44N12O6 (572.3506603999999)
Arg Leu Glu Arg
Arg Leu Arg Glu
Arg Leu Val Trp
C28H44N8O5 (572.3434493999999)
Arg Leu Trp Val
C28H44N8O5 (572.3434493999999)
Arg Asn Lys Arg
C22H44N12O6 (572.3506603999999)
Arg Asn Gln Arg
Arg Asn Arg Lys
C22H44N12O6 (572.3506603999999)
Arg Asn Arg Gln
Arg Gln Asn Arg
Arg Gln Arg Asn
Arg Arg Glu Ile
Arg Arg Glu Leu
Arg Arg Ile Glu
Arg Arg Lys Asn
C22H44N12O6 (572.3506603999999)
Arg Arg Leu Glu
Arg Arg Asn Lys
C22H44N12O6 (572.3506603999999)
Arg Arg Asn Gln
Arg Arg Gln Asn
Arg Val Ile Trp
C28H44N8O5 (572.3434493999999)
Arg Val Leu Trp
C28H44N8O5 (572.3434493999999)
Arg Val Trp Ile
C28H44N8O5 (572.3434493999999)
Arg Val Trp Leu
C28H44N8O5 (572.3434493999999)
Arg Trp Ile Val
C28H44N8O5 (572.3434493999999)
Arg Trp Leu Val
C28H44N8O5 (572.3434493999999)
Arg Trp Val Ile
C28H44N8O5 (572.3434493999999)
Arg Trp Val Leu
C28H44N8O5 (572.3434493999999)
Val Ile Arg Trp
C28H44N8O5 (572.3434493999999)
Val Ile Trp Arg
C28H44N8O5 (572.3434493999999)
Val Leu Arg Trp
C28H44N8O5 (572.3434493999999)
Val Leu Trp Arg
C28H44N8O5 (572.3434493999999)
Val Arg Ile Trp
C28H44N8O5 (572.3434493999999)
Val Arg Leu Trp
C28H44N8O5 (572.3434493999999)
Val Arg Trp Ile
C28H44N8O5 (572.3434493999999)
Val Arg Trp Leu
C28H44N8O5 (572.3434493999999)
Val Trp Ile Arg
C28H44N8O5 (572.3434493999999)
Val Trp Leu Arg
C28H44N8O5 (572.3434493999999)
Val Trp Arg Ile
C28H44N8O5 (572.3434493999999)
Val Trp Arg Leu
C28H44N8O5 (572.3434493999999)
Trp Ile Arg Val
C28H44N8O5 (572.3434493999999)
Trp Ile Val Arg
C28H44N8O5 (572.3434493999999)
Trp Leu Arg Val
C28H44N8O5 (572.3434493999999)
Trp Leu Val Arg
C28H44N8O5 (572.3434493999999)
Trp Arg Ile Val
C28H44N8O5 (572.3434493999999)
Trp Arg Leu Val
C28H44N8O5 (572.3434493999999)
Trp Arg Val Ile
C28H44N8O5 (572.3434493999999)
Trp Arg Val Leu
C28H44N8O5 (572.3434493999999)
Trp Val Ile Arg
C28H44N8O5 (572.3434493999999)
Trp Val Leu Arg
C28H44N8O5 (572.3434493999999)
Trp Val Arg Ile
C28H44N8O5 (572.3434493999999)
Trp Val Arg Leu
C28H44N8O5 (572.3434493999999)
Vitamin D2 glucosiduronate
Ganoderic acid W
Ganoderic acid Ma
3'-N-Acetyl-4'-O-(14-methylpentadecanoyl)fusarochromanone
C33H52N2O6 (572.3825171999999)
IC202A
A N-oxide isolated from Streptoalloteichus sp.1454-19. It is a siderophore which exhibits immunosuppressive activity on a mixed lymphocyte culture reaction (MLCR).
Vitamin D2 3-glucuronide
D018977 - Micronutrients > D014815 - Vitamins > D004872 - Ergocalciferols
Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate
(2Z)-2-(Hydroxymethylene)-3-oxoolean-12-en-28-oic acid phenylmethyl ester
2-[4-(dimethylamino)-3-oxo-4H-pyridin-1-ium-1-yl]ethyl (2-ethoxy-3-hexadecoxypropyl) phosphite
C30H57N2O6P (572.3954031999999)
Tazemetostat
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-[[(2R)-3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
ethyl (2E,4S)-4-[(2S)-2-[(2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanamido]-4-methylpentanamido]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate
C30H44N4O7 (572.3209833999999)
1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
Arg-Asn-Gln-Arg
A tetrapeptide composed of L-arginine, L-asparagine, L-glutamine, and L-arginine joined in sequence by peptide linkages.
1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
(1R,9S,12S,13S,14S,19R,21S)-14-ethyl-9-[(1S,12S,14S,15E)-15-ethylidene-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraen-13-yl]-10-oxa-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6-triene
1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
(3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-yl-beta-D-glucopyranosiduronic acid
(1R,15R,17S)-17-ethyl-6-[(1R,14R,15E)-15-ethylidene-17,18-dimethyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene
2,3-dihydroxypropyl [2-hydroxy-3-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoxy]propyl] hydrogen phosphate
[(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)heptadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxyoctadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)hexadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[(4E,8E,12E)-2-acetamido-3-hydroxytricosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[(4E,8E,12E)-2-(butanoylamino)-3-hydroxyhenicosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)docosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)icosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxynonadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[(4E,8E,12E)-2-(decanoylamino)-3-hydroxypentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
[(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H57N2O6P (572.3954031999999)
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate
(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
cyclo[DL-Nle(Unk)-D-Phe-xiIle-Pip]
C31H48N4O6 (572.3573667999999)
[1-phosphonooxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate
2-[[2-[(4Z,7Z,10Z,13Z)-docosa-4,7,10,13-tetraenoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (9E,11E,13E)-hexadeca-9,11,13-trienoate
2-[[(2R)-3-[(7E,10E,13E,16E)-docosa-7,10,13,16-tetraenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-butanoyloxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-acetyloxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
3-N-Acetyl-4-O-(14-methylpentadecanoyl)fusarochromanone
C33H52N2O6 (572.3825171999999)
N-(5-aminopentyl)-N-(5-{[4-({5-[butylidene(oxido)-lambda(5)-azanyl]pentyl}amino)-4-oxobutanoyl](hydroxy)amino}pentyl)-N-hydroxybutanediamide
Bradykinin (1-5)
C27H40N8O6 (572.3070660000001)
Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE). Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE).
LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)
LSKL, Inhibitor of Thrombospondin (TSP-1) TFA is a latency-associated protein (LAP)-TGFβ derived tetrapeptide and a competitive TGF-β1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) TFA can readily crosse the blood-brain barrier[1][2].
SLLK, Control Peptide for TSP1 Inhibitor(TFA)
SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor.